CN1902158B - N,n-二卤代氨基酸及其衍生物 - Google Patents

N,n-二卤代氨基酸及其衍生物 Download PDF

Info

Publication number
CN1902158B
CN1902158B CN2004800276919A CN200480027691A CN1902158B CN 1902158 B CN1902158 B CN 1902158B CN 2004800276919 A CN2004800276919 A CN 2004800276919A CN 200480027691 A CN200480027691 A CN 200480027691A CN 1902158 B CN1902158 B CN 1902158B
Authority
CN
China
Prior art keywords
composition
group
solution
acid
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN2004800276919A
Other languages
English (en)
Chinese (zh)
Other versions
CN1902158A (zh
Inventor
曼苏尔·巴西里
拉明·纳杰菲
王露
杨简
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novabay Pharmaceuticals Inc
Original Assignee
Novacal Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novacal Pharmaceuticals Inc filed Critical Novacal Pharmaceuticals Inc
Publication of CN1902158A publication Critical patent/CN1902158A/zh
Application granted granted Critical
Publication of CN1902158B publication Critical patent/CN1902158B/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/02—Compounds containing nitrogen-to-halogen bonds
    • C07C239/04—N-halogenated amines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A01N41/04—Sulfonic acids; Derivatives thereof
    • A01N41/08—Sulfonic acid halides; alpha-Hydroxy-sulfonic acids; Amino-sulfonic acids; Thiosulfonic acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
CN2004800276919A 2003-08-18 2004-08-17 N,n-二卤代氨基酸及其衍生物 Expired - Lifetime CN1902158B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49620703P 2003-08-18 2003-08-18
US60/496,207 2003-08-18
PCT/US2004/026603 WO2005020896A2 (en) 2003-08-18 2004-08-17 N,n-dihalogenated amino acids and derivatives

Publications (2)

Publication Number Publication Date
CN1902158A CN1902158A (zh) 2007-01-24
CN1902158B true CN1902158B (zh) 2011-04-06

Family

ID=34272488

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2004800276919A Expired - Lifetime CN1902158B (zh) 2003-08-18 2004-08-17 N,n-二卤代氨基酸及其衍生物

Country Status (20)

Country Link
US (2) US7462361B2 (enExample)
EP (2) EP2725008A1 (enExample)
JP (1) JP4994033B2 (enExample)
KR (1) KR101057609B1 (enExample)
CN (1) CN1902158B (enExample)
AR (1) AR047757A1 (enExample)
AU (1) AU2004268546B2 (enExample)
BR (1) BRPI0413660A (enExample)
CA (1) CA2535926C (enExample)
DK (1) DK1656095T3 (enExample)
ES (1) ES2444845T3 (enExample)
IL (1) IL173726A (enExample)
MX (1) MXPA06001898A (enExample)
NZ (1) NZ545654A (enExample)
PL (1) PL1656095T3 (enExample)
PT (1) PT1656095E (enExample)
SG (1) SG149043A1 (enExample)
SI (1) SI1656095T1 (enExample)
TW (1) TWI376364B (enExample)
WO (1) WO2005020896A2 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393522B2 (en) * 2000-01-12 2008-07-01 Novabay Pharmaceuticals, Inc. Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
JP5140218B2 (ja) 2001-09-14 2013-02-06 有限会社コヒーレントテクノロジー 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法
MXPA03007923A (es) 2001-12-05 2005-02-17 Micromed Lab Inc Metodo y aparato para producir agua potencial oxidativa reductiva positiva y negativa.
CA2535926C (en) * 2003-08-18 2012-10-09 Novacal Pharmaceuticals, Inc. N,n-dihalogenated amino acids and derivatives
US9168318B2 (en) 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
CA2602522C (en) 2005-03-23 2014-09-09 Oculus Innovative Sciences, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
US9498548B2 (en) 2005-05-02 2016-11-22 Oculus Innovative Sciences, Inc. Method of using oxidative reductive potential water solution in dental applications
JP2009511493A (ja) * 2005-10-06 2009-03-19 ノバベイ・ファーマシューティカルズ・インコーポレイテッド Ｎ−ハロゲン化アミノ酸を使用する、尿路感染症（ｕｔｉ）を含む細菌感染症および真菌感染症の予防のためのシステムおよび方法
JP5723084B2 (ja) 2006-01-20 2015-05-27 オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド 酸化還元電位水溶液を用いた副鼻腔炎の予防または治療方法
US20070292489A1 (en) * 2006-06-14 2007-12-20 Mansour Bassiri Method for treatment of wound treatment using aganocides
TW200843787A (en) 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them
US20080288019A1 (en) * 2007-01-31 2008-11-20 Adam Heller Electrochemical management of pain
UY31059A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado
UY31058A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
UY31056A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Fromulaciones aminocido n-halogenado y metodos de limpieza y desinfeccion
UY31057A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado que contiene acido alifatico
US7524512B2 (en) * 2007-07-13 2009-04-28 Di Bartolomeo Joseph R Composition and method for the prevention and relief of the symptoms of an incompetent or patulous Eustachian tube
UY31055A1 (es) * 2008-02-01 2008-10-31 Alcon Res Ltd Sales antimicrobianas de aminoacido n-halogenado
EP2265267B1 (en) 2008-04-10 2016-09-21 Waldemar Gottardi Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
US20110091570A1 (en) * 2008-04-15 2011-04-21 Waldemar Gottardi Compositions and Devices for Antisepsis and Anticoagulation
AU2009281998A1 (en) * 2008-08-12 2010-02-18 Novabay Pharmaceuticals, Inc. Antimicrobial gel formulations
JP5753785B2 (ja) * 2008-11-07 2015-07-22 ノバベイ・ファーマシューティカルズ・インコーポレイテッドＮｏｖａｂａｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 抗菌オキサゾリジノン、ヒダントインおよびイミダゾリジノン組成物
EP2341886B1 (en) 2008-11-07 2015-08-26 NovaBay Pharmaceuticals, Inc. Antimicrobial n-chlorinated compositions
WO2010091280A1 (en) 2009-02-06 2010-08-12 Alcon Research, Ltd. N-halogenated amino acid formulations comprising phosphine or amine oxides
CA2756760A1 (en) * 2009-03-27 2010-11-04 Gojo Industries, Inc. Compositions and methods for screening and using compounds antagonizing spore-surface interactions
WO2010124237A1 (en) * 2009-04-24 2010-10-28 Novabay Pharmaceuticals Inc. Methods of treating infections of the nail
MX348304B (es) 2009-06-15 2017-06-02 Invekra S A P I De C V Solucion que contiene acido hipocloroso y metodos para usar la misma.
BR112012019565A2 (pt) * 2010-02-04 2016-08-16 Novabay Pharmaceuticals Inc formulações antimicrobianas com base em polissacarídeo
AU2011317223A1 (en) * 2010-10-19 2013-05-23 Novabay Pharmaceuticals, Inc. Antimicrobial polyether and polyol compounds
WO2012157699A1 (ja) * 2011-05-18 2012-11-22 味の素株式会社 動物用免疫賦活剤、それを含む飼料及びその製造方法
US9642780B2 (en) 2011-06-15 2017-05-09 Rls Global Ab Detection and removal of carious dentin tissue
US9028807B2 (en) 2012-04-05 2015-05-12 Ues, Inc. Synthesis models for antimicrobial agents via the halogenation of organic/inorganic composites
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
DK3469117T3 (da) 2016-06-09 2022-02-28 De Nora Holdings Us Inc Elektrolytisk fremstilling af organiske chloraminopløsninger
US11172683B2 (en) * 2018-01-30 2021-11-16 Buckman Laboratories International, Inc. Synergistic combinations of monochloramine and organic acid, and methods of using the same for microbial control
CN111116406B (zh) * 2019-12-31 2020-12-25 吉林大学 一种能在物品表面形成杀菌涂层的卤胺及在物品表面形成杀菌涂层的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386103A (en) * 1981-01-30 1983-05-31 Merck & Co., Inc. Dichloroamino acid derivatives useful as potent germicidal and fungicidal agents
US6451761B1 (en) * 1999-09-29 2002-09-17 Queen's University At Kingston N′N′-dichlorinated omega-amino acids and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998945A (en) 1972-06-12 1976-12-21 National Patent Development Corporation Dental treatment
US3950536A (en) * 1974-02-01 1976-04-13 Sol Joseph Barer N,N-Dichloro substituted aminocarboxylic acids as bactericides and fungicides
US4015008A (en) * 1974-02-01 1977-03-29 National Patent Development Corporation N,N-dichloro substituted aminocarboxylic acids as microbiocides
US3966796A (en) 1974-06-14 1976-06-29 Interx Research Corporation N-chloro-amino acid derivatives activity
US4045578A (en) 1974-06-14 1977-08-30 Interx Research Corporation N-chloro-amino acid derivatives exhibiting antibacterial activity
US5055492A (en) 1985-06-14 1991-10-08 Masonic Medical Research Laboratory Method for affecting reproductive cycle of insects
US5096700A (en) 1990-09-28 1992-03-17 The Procter & Gamble Company Halogenated aminohexanoates and aminobutyrates antimicrobial agents
DE4041703C2 (de) 1990-12-24 1993-10-21 Waldemar Dr Gottardi Alkalimetallsalze des N-Chlortaurins in kristalliner Form, Verfahren zu deren Herstellung und deren Verwendung
JP3759757B2 (ja) 1994-01-13 2006-03-29 相互薬工株式会社 殺菌剤
US5593714A (en) * 1994-12-06 1997-01-14 Hirsch; Gerald P. Method of pressure preservation of food products
US5753701A (en) 1996-10-25 1998-05-19 University Of Kentucky N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection
DE19712565A1 (de) 1997-03-25 1998-10-01 Thomas W Dr Stief Arzneimittel auf der Basis eines Singulett-Sauerstoff erzeugenden Agenzes
DE19816102C1 (de) 1998-04-10 1999-09-16 Waldemar Gottardi Verfahren zum Inaktivieren von Viren in Proteinlösungen, Verwendung von N-Chlortaurin in dem Verfahren sowie nach dem Verfahren hergestellte Proteinlösungen
EP1239853B1 (de) 2000-09-14 2006-11-08 Waldemar Gottardi Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
FR2819723B1 (fr) 2001-01-23 2006-11-17 Arnaud Mainnemare Composition halogene, son procede de preparation et ses utilisations
CA2535926C (en) 2003-08-18 2012-10-09 Novacal Pharmaceuticals, Inc. N,n-dihalogenated amino acids and derivatives
US7129259B2 (en) 2003-12-17 2006-10-31 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
TWI386201B (zh) 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
TW200843787A (en) 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386103A (en) * 1981-01-30 1983-05-31 Merck & Co., Inc. Dichloroamino acid derivatives useful as potent germicidal and fungicidal agents
US6451761B1 (en) * 1999-09-29 2002-09-17 Queen's University At Kingston N′N′-dichlorinated omega-amino acids and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Shirley Abrantes et al.Determination of Extractable Biocides in Paper FoodPackaging Materials Using Micellar ElectrokineticChromatography.J. Microcolumn Separations10 5.1998,10(5),387-391.
Shirley Abrantes et al.Determination of Extractable Biocides in Paper FoodPackaging Materials Using Micellar ElectrokineticChromatography.J. Microcolumn Separations10 5.1998,10(5),387-391. *

Also Published As

Publication number Publication date
NZ545654A (en) 2009-12-24
CN1902158A (zh) 2007-01-24
EP1656095A2 (en) 2006-05-17
HK1103713A1 (en) 2007-12-28
CA2535926C (en) 2012-10-09
WO2005020896A2 (en) 2005-03-10
EP1656095B1 (en) 2014-01-01
WO2005020896A3 (en) 2006-10-05
SI1656095T1 (sl) 2014-04-30
US20090023812A1 (en) 2009-01-22
PL1656095T3 (pl) 2014-04-30
IL173726A (en) 2013-06-27
JP4994033B2 (ja) 2012-08-08
BRPI0413660A (pt) 2006-10-24
AU2004268546A1 (en) 2005-03-10
US20050065115A1 (en) 2005-03-24
US7893109B2 (en) 2011-02-22
PT1656095E (pt) 2014-03-11
EP2725008A1 (en) 2014-04-30
ES2444845T3 (es) 2014-02-27
AR047757A1 (es) 2006-02-22
KR101057609B1 (ko) 2011-08-18
DK1656095T3 (en) 2014-03-10
MXPA06001898A (es) 2006-05-31
SG149043A1 (en) 2009-01-29
CA2535926A1 (en) 2005-03-10
EP1656095A4 (en) 2007-11-28
TW200520749A (en) 2005-07-01
TWI376364B (en) 2012-11-11
KR20060065701A (ko) 2006-06-14
JP2007502826A (ja) 2007-02-15
IL173726A0 (en) 2006-07-05
US7462361B2 (en) 2008-12-09
AU2004268546B2 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
CN1902158B (zh) N,n-二卤代氨基酸及其衍生物
AU2006208046B2 (en) N-halogenated amino acids and N, N-dihalogenated amino acids in combination with hypohalous acids
EP2120965B1 (en) N-halogenated amino compounds and derivatives
JP2012508251A (ja) 抗菌性ｎ−塩素化組成物
HK1103713B (en) N,n-dihalogenated amino acids and derivatives
HK1117748A (en) N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1103713

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: NOVABAY PHARMACEUTICALS INC.

Free format text: FORMER OWNER: NORWAKOL PHARMACEUTICAL CO.

Effective date: 20110907

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20110907

Address after: California, USA

Patentee after: NOVABAY PHARMACEUTICALS, Inc.

Address before: California, USA

Patentee before: NOVACAL PHARMACEUTICALS, Inc.

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1103713

Country of ref document: HK

CX01 Expiry of patent term

Granted publication date: 20110406

CX01 Expiry of patent term